What is Zortress (everolimus), and what is it used for?
Zortress is a brand of everolimus, an immunosuppressant used to help prevent organ rejection after transplantation. It works by reducing immune activity. [1]
For which transplants is Zortress approved?
Zortress is used in transplant settings where everolimus-based immunosuppression is indicated, including kidney transplant patients. [1]
How does Zortress compare with other immunosuppressants after a transplant?
Zortress is an mTOR inhibitor (everolimus). In practice, clinicians may use it as an alternative or add-on to other immunosuppressants depending on the transplant regimen and patient factors, such as tolerance, kidney function goals, and rejection risk. [1]
What side effects are patients commonly concerned about?
Because Zortress suppresses immune responses, common concerns include infection risk and mouth ulcers, along with other potential medication-related effects. [1]
How is Zortress taken, and what do dosing schedules usually depend on?
Zortress dosing is individualized based on the transplant regimen and patient factors. The prescribing information includes specific instructions for how it should be taken and how dosing may need adjustment. [1]
What monitoring is typically required while taking Zortress?
Patients on Zortress are typically monitored for immunosuppressive safety and drug effects, which can include lab tests referenced in the prescribing information. [1]
Who makes Zortress, and what should patients know about availability?
Zortress is an everolimus product marketed under that brand name. Patients can review the brand’s prescribing information for the most current guidance on indications, dosing, and safety. [1]
Where can I find the official prescribing information for Zortress?
You can use the official prescribing information for complete details on indications, dosing, contraindications, warnings, and side effects. [1]
Sources:
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=()